Agio Paper (516020)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Book value per share is positive at ₹1.58, so the balance sheet is not reported as insolvent.
• The stock trades on NSE/BSE with an observable price and a 52-week range.
• No dividend is being paid, which removes a cash outflow a loss-making company cannot afford.

Concerns

• ROE of -820.08% and ROCE of -3.24% show severe capital destruction.
• Latest quarter has sales of ₹0 Cr and net loss of ₹1 Cr; profit growth of -31.58% indicates widening losses.
• Piotroski F-Score of 2/9 points to very weak financial health.
• P/B of 3.66 means the market price is a steep premium to book value even though earnings are negative.

AI Analysis

When I look at Agio Paper, the first thing that hits me is the return on equity: negative 820 percent. That is not a business; it is a capital destroyer. A paper company with a book value of only ₹1.58 per share and a price of ₹5.79 means I am being asked to pay 3.66 times book for operations that cannot earn a profit. The latest quarter tells the story: sales of ₹0 crore and a net loss of ₹1 crore. My valuation methods do not work when earnings are absent. Graham would demand positive earnings, low debt, and a margin of safety. This stock has none. The Piotroski F-Score is 2 out of 9, which is very weak. Return on capital employed is negative 3.24 percent, so even the money tied up in the business is not generating a return. Sales growth is zero, but with zero quarterly sales, that is not stability; it is emptiness. Profit growth is negative 31.58 percent, meaning losses are becoming larger, not smaller. With a market cap of ₹10 crore, this is a micro-cap, but small size is not a substitute for quality. The 52-week range of ₹3.28 to ₹7.10 suggests price swings driven by speculation, not value. There is no dividend, no promoter holding data, and no clear balance-sheet strength. Book value is positive, but at a P/B of 3.66 I am paying a steep premium for a book that is being eroded by losses. Maybe this is a turnaround case. But a turnaround requires evidence: sales restarting, costs cut, debts under control. I see none. As Graham said, price is what you pay, value is what you get. Here I would be paying a premium for negative earnings and a failing balance sheet. This is not investing; it is hope. I will leave it alone.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer